BACKGROUND: SMARCB1 (INI-1)-deficient sinonasal carcinoma (IDSNC) is a newly described, poorly differentiated carcinoma. Herein, the authors describe the cytopathologic features of IDSNC in fine-needle aspiration (FNA) samples. METH-ODS: The pathology archives of 2 academic institutions were searched for cases of IDSNC with available cytologic materials. All available slides were reviewed and a detailed morphological analysis was performed. RESULTS: Six cases were identified from 6 patients. FNA specimens were obtained from metastatic sites (4 cases), a local disease recurrence 
INTRODUCTION
Carcinomas of the sinonasal tract represent approximately 3% to 5% of all head and neck cancers. 1 Poorly differentiated sinonasal carcinomas represent an aggressive and difficult-to-classify subset of these tumors. The term "sinonasal undifferentiated carcinoma" (SNUC) was proposed in the mid-1980s for aggressive sinonasal malignancies that demonstrated epithelioid differentiation, typically through immunohistochemistry for cytokeratins or epithelial membrane antigen. 2 Since that time, this SNUC grouping has undergone reclassification as new entities are described, often based on unique molecular abnormalities. 3 One such molecular abnormality is the inactiva- To our knowledge, only a few case series have been published to date describing the clinicopathologic features of IDSNC, 4, 6, 7 and only 1 has described the cytopathologic features of this malignancy on a fine-needle aspiration (FNA) sample from a primary tumor. 8 Many of the cases described in these series have demonstrated basaloid histologic features resembling nonkeratinizing squamous cell carcinomas (SCCs), whereas a minority were oncocytic or plasmacytoid, resembling myoepithelial or rhabdoid malignancies. These carcinomas have been uniformly keratin positive and negative for SMARCB1, nuclear protein in testits (NUT), and human papillomavirus, with variable expression of squamous and neuroendocrine markers. These malignancies are aggressive, with frequent invasion into the brain and skull base, with regional and distant metastases. Of the cases reported to date, approximately one-half of the patients have died of disease within the reported follow-up periods.
3,4,6,7
Herein we describe the cytopathologic features of IDSNC in FNA samples of primary, recurrent, and metastatic tumors.
MATERIALS AND METHODS

Case Selection
This retrospective archival search did not require patient consent and was performed under approval from the institutional review board of the University of Virginia. The pathology archives of the University of Virginia and The University of Texas MD Anderson Cancer Center were searched for cytology cases originally diagnosed or reclassified as IDSNC. Three such cases were found at each institution with FNA samples having been collected between 2000 and 2016. All available slides including smear, ThinPrep (Hologic, Marlborough, Massachusetts), cell block, and ancillary study materials were pulled from the archives and reviewed. All 6 cases had at least Papanicolaou-stained and Diff-Quik-stained smears available for review; 1 case also had liquid-based preparations and 2 cases had cell block preparations. A detailed morphological analysis was performed with review of patient demographics and clinical history, including available follow-up.
Immunoperoxidase Staining
Diagnostic immunohistochemistry (IHC) was performed on the biopsy/surgical resection specimen in 5 cases and on the cell block material of 1 case.
Surgical specimens and cell block preparations were fixed in buffered formalin and embedded in paraffin for routine histologic examination. IHC studies were performed on 4-mm sections cut from paraffin blocks using a fully automated system (Benchmark XT System; Ventana Medical Systems Inc, Tucson, Arizona) and the following antibodies: p63 ( 
RESULTS
Demographic and Clinical Data
Six cases were identified from 6 patients. FNA specimens were obtained from metastatic sites (4 cases), a local disease recurrence (1 case), and a primary lesion extending into the orbit (1 case). The demographic and clinical features are summarized in Table 1 . The patients included 4 men and 2 women ranging in age from 32 to 87 years. The cytology diagnosis from FNA sampling was the first diagnostic sampling in only 1 case, whereas the cytologic diagnoses confirmed metastatic disease and recurrent disease in the other 5 cases.
The diagnosis of IDSNC was the original diagnosis in 2 cases, whereas the other cases were diagnosed as SNUC and SCC on original sampling before the entity of IDSNC had been described. These cases were reclassified after they were found to demonstrate loss of INI-1 via IHC staining.
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Cytomorphologic Features
The cytomorphologic characteristics are summarized in Table 2 . The majority of cases produced cellular specimens with features of a basaloid, nonkeratinizing SCC (Fig. 1) . These smears demonstrated cohesive clusters and sheets of oval to polygonal cells with scant cytoplasm and indistinct cell borders present within a background of necrotic debris. Two cases had single rhabdoid cells with more abundant cytoplasm. The nuclei of all cases generally were small and uniform with fine chromatin, small nucleoli, and mild nuclear membrane irregularities. Although moderate anisonucleosis and multinucleation were observed in 1 case, no overt nuclear pleomorphism was noted in any case. Apoptotic bodies were common in 5 of 6 cases, with readily identifiable mitoses observed in 3 of 6 cases. These features, in addition to the background necrotic debris, suggested the high-grade nature of the malignancy in the face of the rather uniform nuclear features.
No spindle or clear cell features were found to be present in any of these 6 cases. No gland or pseudo-gland formations were noted. In the cases that were squamoid, no keratinization was present. Although 3 of the 6 cases demonstrated small, intervening blood vessels, no matrix material was present in any of the aspirate smears, liquidbased preparations, or cell blocks.
These cytomorphologic features were found to be similar to those noted on the corresponding histologic material, which also demonstrated nonkeratinizing squamoid features in the majority of cases with focal rhabdoid appearance, but no overt glandular or squamous differentiation (Fig. 2) .
IHC Profile
The IHC findings are summarized in Table 3 . IHC staining was performed on biopsy or surgical resection specimens obtained before the FNA (5 of 6 cases) or on the (Fig. 3) . All cases were negative for neuroendocrine markers and aberrant p16 staining; wild-type p16 staining, defined as scattered nuclear positivity noted in a haphazard, nondiffuse/non-block-like pattern, was observed in the 3 cases for which it was performed.
DISCUSSION
The diagnosis of head and neck carcinomas is a daunting challenge given the ever-expanding list of potential entities that must be considered. This challenge is compounded on cytological evaluation due to the increasing necessity to perform ancillary studies to appropriately categorize these malignancies with limited materials. FNA sampling often is used as a first-line diagnostic modality in patients with head and neck neoplasms because it generally is a readily accessible procedure in many practice settings and is minimally invasive. The same is true for using cytologic sampling to confirm disease recurrence and/or metastases. However, given the extensive list of potential differential diagnoses that may be generated based on the anatomic location and cytomorphologic features of this malignancy, cell block or biopsy material is needed to make a definitive diagnosis of IDSNC by demonstrating loss of INI-1 expression using IHC to exclude morphologically similar entities that may be considered in the differential diagnosis. Fluorescence in situ hybridization also may be used to demonstrate the deletion of SMARCB1, as described by Agaimy et al. 6 The differential diagnosis for this lesion is broad and encompasses many of the poorly differentiated and basaloid malignancies of the sinonasal tract ( Table 4) . As can be noted from the early diagnoses made in the cases presented herein, SCC and SNUC often are high on the list of diagnostic considerations in cases of IDSNC. The diffuse immunoreactivity for p63 generally observed in IDSNC and the reported variable expression of p16 would overlap with the expected findings of a nonkeratinizing/ basaloid SCC. Positivity for p63 also would be expected in a NUT midline carcinoma. However, IDSNCs often lack obvious histologic evidence of squamous differentiation; in addition, when human papillomavirus testing has been performed on p16-positive cases of IDSNC, the molecular results have been reported to be negative. 5, 6 The lack of NUT gene rearrangement and demonstration of the absence of INI-1 nuclear expression will definitively distinguish IDSNC from SNUC, NUT carcinomas, and SCC. The cytopathologic differential diagnosis for lesions with a plasmacytoid appearance in the head and neck also could include entities such as neuroendocrine tumors/carcinomas, myoepithelial carcinoma, melanoma, and plasmacytomas, to name a few. Melanomas and neuroendocrine carcinomas generally would demonstrate more overt features of malignancy, including nuclear pleomorphism and hyperchromasia. In addition, strongly cohesive groups of cells would be less likely to be observed in these tumors. S100 protein would be expressed in cases of melanoma, but is not expressed in IDSNC. 8 Plasma cells from a plasmacytoma could demonstrate the more uniform and bland cytomorphologic features noted in many IDSNC cases, but a perinuclear hof and CD138 immunoreactivity would not be observed. In addition, cohesive clusters would not be an expected cytologic feature of a plasmacytoma. Neuroendocrine markers, including synaptophysin and chromogranin, have been reported to be positive in a subset of IDSNC cases, thereby presenting a potential pitfall in regard to a well-differentiated neuroendocrine tumor or ectopic sinonasal pituitary adenoma. However, p63 expression would not be expected in these tumors. Plasmacytoid myoepithelial carcinomas would closely resemble the uniform, basaloid appearance of an IDSNC on cytologic sampling, with both entities demonstrating bland, monotonous cytologic features with increased mitotic activity and a background of necrosis. In addition, although myoepithelial tumors may express p63, they often express other myoepithelial proteins such as S100 protein.
In the setting of a known sinonasal primary tumor, the demonstration of loss of INI-1 is thought to be specific for IDSNC; however, several other malignancies also have been shown to demonstrate nuclear loss of INI-1 expression. Other malignancies in which INI-1 inactivation has been found include pediatric atypical teratoid/rhabdoid tumor, epithelioid sarcoma, renal medullary carcinoma, rhabdoid tumors of the kidney and soft tissue, myoepithelial carcinoma of the soft tissue, epithelioid malignant peripheral nerve sheath tumor, and extraskeletal myxoid chondrosarcoma. These entities usually occur in young patients, have rhabdoid morphology, and are aggressive malignancies with poor prognoses. 9 Although the clinical course and appearance of these malignancies may be similar to those of IDSNC, the disparate age at the time of presentation and the location of the primary tumor make it unlikely that they would raise a diagnostic dilemma.
Myoepithelial carcinoma may present the only other INI-1-deficient malignancy that could occur primarily in the head and neck region of an adult, and this entity would be distinguished from IDSNC by myoepithelial marker expression as mentioned above. A diagnosis of IDSNC can be suspected on FNA specimens from adult patients with high-grade sinonasal carcinomas that have either a nonkeratinizing squamoid or rhabdoid morphology. Clinical history and the availability of material for IHC are keys in confirming the diagnosis.
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